An improved bronchial provocation test with dry powder adenosine instead of nebulised adenosine monophosphate (AMP) Source: International Congress 2017 – Monitoring asthma control Year: 2017
PBF-680, an oral A1 adenosine receptor antagonist, inhibits adenosine monophosphate (AMP) airway hyperresponsiveness (AHR) in mild-to-moderate asthma: a Phase-IIa proof-of-concept trial Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020
The adenosine A2A -Receptor is not involved in adenosine induced bronchoconstriction in asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 103s Year: 2003
Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine Source: Eur Respir J 2002; 19: 611-616 Year: 2002
Inhibition of basophil activation by adenosine and its agonists Source: Eur Respir J 2001; 18: Suppl. 33, 532s Year: 2001
Adenosine but not the A2A adenosine receptor agonist, CGS 21680 attenuates the endothelial cell barrier disruption induced by lipopolysaccharide Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011
Adenosine 5' – triphosphate (ATP) and adenosine 5' – monophosphate (AMP) challenge testing in healthy non-smokers and patients with mild asthma Source: Eur Respir J 2003; 22: Suppl. 45, 350s Year: 2003
Modulation by cAMP of IL-1β-induced eotaxin and MCP-1 expression and release in human airway smooth muscle cells Source: Eur Respir J 2003; 22: 220-226 Year: 2003
Effect of an inhaled adenosine A2A agonist on the allergen induced late asthmatic response Source: Eur Respir J 2003; 22: Suppl. 45, 204s Year: 2003
Dose response to budesonide using adenosine monophosphate (AMP) bronchial challenge: assessment of two dry powder inhalers Source: Eur Respir J 2002; 20: Suppl. 38, 502s Year: 2002
Cellular and gas exchange responses to adenosine 5‘-monophosphate (AMP) challenge in mild asthma Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004
Cyclic AMP mediates the anti-asthma properties of the lidocaine analog JMF2-1 Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012
Interactive inhibitory effects of formoterol and montelukast on activated human neutrophils Source: Eur Respir J 2010; 36: 1417-1424 Year: 2010
Prostaglandin D2 (PGD2 ) and tryptase release into blood after adenosine and methacholine challenges in asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006
Association between atopic status and airway reactivity to methacholine and adenosine monophosphate Source: Eur Respir J 2001; 18: Suppl. 33, 102s Year: 2001
Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects Source: Eur Respir J 2008; 31: 311-319 Year: 2008
Effect of thromboxane A2 (TXA2 ) synthase inhibitor and TXA2 receptor antagonist alone and in combination on antigen-induced bronchoconstriction in guinea pigs Source: Eur Respir J 2001; 18: Suppl. 33, 264s Year: 2001
Involvement of angiotensins on bronchomotor effects of adenosine Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009
The role of CPA (adenosine A1 agonist) in airway reflexes Source: Annual Congress 2004 - Neural regulation of airways and cough Year: 2004
Inhaled corticosteroids and leukotriene receptor antagonists induce protection against adenosine 5‘monophosphate induced bronchospasm in a synergic fashion Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007